Pacific Biosciences widens losses

Pacific Biosciences of California Inc. (Nasdaq: PACB) widened first quarter losses more than expected sending the stock price down $1.12 to close at $4.05.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.